Protagonist Therapeutics IncHere is the public summary page for Protagonist Therapeutics Inc. Please login to see the complete information for Protagonist Therapeutics Inc including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Protagonist Therapeutics Inc stacks up relative to its peers. |
| Darwin Score | +32 |
| Ticker | PTGX |
| Latest Price | 56.64 USD as of close on 16-Jul-2025 |
| 3 Month price range | 42.01 to 56.37 USD |
| Market Capitalisation | 3.42Bn USD |
| Country | United States of America |
| Region | North America |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Sub-Industry | Biotechnology |
| Description | Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing Rusfertide, an injectable mimetic of hepcidin that is in phase 3 clinical trials for the treatment of polycythemia vera; Icotrokinra, an orally delivered investigational drug which is in phase 3 clinical trials indicated to block biological pathways targeted by marketed injectable antibody drugs; and PN-943, an orally delivered, gut-restricted alpha 4 beta 7 specific integrin antagonist completed a phase 2 clinical trials in patients with moderate to severe ulcerative colitis. The company also develops IL-17 oral peptide antagonist PN-88,1 an oral metabolic/obesity peptide program, and an oral hepcidin mimetic/ferroportin blocker that is in pre-clinical stage. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California. See More ... |
| Company URL | https://www.protagonist-inc.com |
| See Darwins Full Analysis for Protagonist Therapeutics Inc |
Tell Me About
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Protagonist Therapeutics Inc. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | +30 |
| Sentiment | News and Candle Patterns. | 0 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | 0 |
| Flow | Institutional, Fund and Insider buying and selling. | -9 |
| Models | Forecast models. | +11 |
Alerts
There are 5 live alerts for Protagonist Therapeutics Inc.
- Price is at a 6d high. (Positive)
- Overbought - The 5 month RSI is +71.2. (Negative)
- Divergence: Px Down & OBV Up last 20 days. This alert has occurred 97 times over the last last year. The average forward returns are 1.2% over 5 days, 3.4% over 10 days, 3.5% over 15 days and 3.2% over 20 days. (Positive)
- Golden Cross: 5 & 20 dma. This alert has occurred 10 times over the last last year. The average forward returns are 2.0% over 5 days, 3.3% over 10 days, 8.3% over 15 days and 6.3% over 20 days. (Positive)
- 5d RSI Overbought. This alert has occurred 63 times over the last last year. The average forward returns are 3.1% over 5 days, 3.9% over 10 days, 2.4% over 15 days and 2.8% over 20 days. (Positive)
Peer Comparison
There are 5 peers of Protagonist Therapeutics Inc.
| Asset Name | Industry Group | Asset Score |
|---|---|---|
| Carisma Therapeutics Inc (CARM) | Biotechnology | -18 |
| Klotho Neurosciences Inc (KLTO) | Biotechnology | +32 |
| Ligand Pharmaceuticals Inc (LGND) | Biotechnology | +25 |
| Vericel Corp (VCEL) | Biotechnology | -7 |
| Xencor Inc (XNCR) | Biotechnology | -27 |
Share 
